Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. AML Therapy With Irradiated Allogeneic Cells

    ... platelet count 150,000 to 440,000/mm^3 DONOR: hemoglobin / hematocrit ; 12.5-18 g/dl, 38 to 54% DONOR: not ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  2. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... of the lung for carbon monoxide (DLCO) (corrected for hemoglobin ) of < 60% predicted; patients who are unable to perform ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  3. Fludarabine/Clofarabine/Busulfan Combined With SAHA in Acute Leukemia

    ... FVC and DLCO at least 45% of expected corrected for hemoglobin . Children unable to perform pulmonary functions must have an ...

    Clinical Trial last updated 06/06/2016 - 11:07am.

  4. Phase I, Dose Escalation Study of Decitabine

    ... Absolute neutrophil count ≥ 1000; and; Hemoglobin ≥ 8 g/dL (un-transfused); ...

    Clinical Trial last updated 06/06/2016 - 9:44am.

  5. Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

    ... be willing to accept/continue transfusions to treat low hemoglobin levels Subjects must have a life expectancy of > 6 months ...

    Clinical Trial last updated 06/06/2016 - 2:18pm.

  6. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... lung for carbon monoxide (DLCO) ≥ 40% (adjusted for hemoglobin ) and forced expiratory volume in one second (FEV1) ≥ 50% ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  7. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... the lung for carbon monoxide (DLCO) >50% (adjusted for hemoglobin ), and forced expiratory volume in one second (FEV1) or forced ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  8. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... FEV1, FVC and DLCO >/= 50% of expected, corrected for hemoglobin . Adequate liver function: a. Bilirubin </= 1.5 mg/dl ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  9. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... diffusion capacity of least 50% predicted, corrected for hemoglobin . Patient or patient's legal representative, able to sign ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  10. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... diffusion capacity of least 50% predicted value for hemoglobin concentration (Myeloablative Regimen 1, Reduced Intensity ...

    Clinical Trial last updated 06/06/2016 - 10:28am.